Help for cytotoxic-T-cell responses is mediated by CD4O signalling

Nature

Volumn 393, Issue 6684, 1998, Pages 478-480

  Bennett, Sally R M ^a   Carbone, Francis R ^a   Karamalis, Freda ^a   Flavell, Richard A ^a   Miller, Jacques F A P ^a   Heath, William R ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD8 ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL DESTRUCTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; CD40 LIGAND; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; OVALBUMIN; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0032482356     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/30996     Document Type: Article

References (30)

1. Keene, J. A. & Forman, J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 155,768-782 (1932).
2. von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B. 8c Whitton, J. L CD4-deficicnt mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance ot subsequent virus challenge. J. Virol 70,1072-1079 (1996).
3. Cardin, R. D., Brooks, J. W., Sarawar, S, R. & Doherty, P. C. Progressive loss of CDS T cell-mediated control of a vherpesvirus in the absence of CD4 T cells. J. Exp. hied. 184, 863-871 (1996).
4. Bennett, S. R., Carbone, F. R., Karamalis, F., Miller, J. F. A. P. & Heath, W. R. Induction of a CDS cytotoxic T lymphocyte response by cross-priming requires cognate CD4 help. J. Exp. Med. 186,6570(1997).
5. Guerder, S. & Matzïnger, P. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 176, 553-564(1992).
6. Butler, R. M., Holmes, K. L, Hugin, A., Frederickson, T. N. & Morse, H. C. Induction of cytotoxic Tcell responses in vivo m the absence ofCD4 helper cells. Nature 328, 77-79 (1987),
7. Ahmed, R., Butler, L. D. & Bhatti, L. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-ccIl and antibody respones. J. Virol 62, 2102-2106 (1988).
8. Ke, Y. & Kapp, J. A. Oral antigen inhibits priming of DS'CTL, CD4 T cells, and antibody responses while activating D8 suppressor T cells. J. Immunol 156,916-921 (1996).
9. Carbone, F. R. & Bevan, M. J. Class I-restricted processing and presentation of exogenous cellassociated antigen in vivo. J. Exp. Mat 171,377-387 (1990).
10. Stout, R. D. & Sullies, J. The many roles of CD40 in cell-mediated inflammatory responses. Immunol Tbttoy 17, 437-492 (1996).
11. Grewal, I. S. & Flavell, R. A. A central role of CD40 ligand in the regulation of CD4 T-cell responses. ImmunoL Today 17, 410-414 (1996).
12. Yang, Y. et al. Transient subversion of CD40 ligand function diminishes immune responses to adenovirus vectors in mouse liver and lung tissues. J. Virol. 70,6370-6377 (1996).
13. Borrow, P. et al CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CDS CTL response. J. Exp. Med. 183,2129-2142 (1996).
14. Yang, Y. & Wilson, J. M. CD4U ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. SnVmre 273, 1862-1864(1996).
15. Roy, M., Waldschmidt, T., Aruffo, A., Ledbelter, J. A. & Noëlle, R. I. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4 T cells. J. Immunol 151, 2497-2510 (1993).
16. Sad, S. ft al Cytotoxicity and weak CD40 ügand expression of DS type 2 cytotoxic T cells restricts their potential B cell helper activity. Ear. }. Immunol 27, 914-922 .(1997).
17. Rolink, A., Melchers, F. & Andersson, J. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5, 319-330 (1996).
18. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytusis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182,389-400 (1995).
19. Grewal, I. S. et al Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273, 1864-1867 (1996).
20. Guo, Y. er al. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. /, Exp. Med. 184,955-961 (1996).
21. Shinde, S. et al CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second stimulatory molecule rapidly up-regulated by CD40L J. Immunol 157, 2764-2768(1996).
22. Alderson, M. R. et al CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178,669-674 (1993).
23. Wagner, D. J., Stout, R. D. & Suttles, J. Role of the CD40-CD40 ligant interaction in CD4 T cell contact-dependent activation of monocyte interleukin-1 synthesis. Ear. J. Immunol 24, 3148-3154 (1994).
24. Shu, U. ft al Activated T cells induce interleukin-12 production by monocytes via CD40-CD4Q lîgand interaction. Ear. J. JmmunoL 25,1125-1128 (1995).
25. Kiener, P. A. et ai Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol 155,4917-4925 (1995).
26. Fuchs, E. J. & Matzinger, P. B cells turn off virgin but not memory T cells. Science 258,1156-1159 (1992).
27. Armitage, R. J. ff al CD40 ligand is a T cell growth factor. Eur. J. Immunol 23, 2326-2321 (1993).
28. Whitmirc, J. K., Slifka, M. K., Grewal, I. S., Flavell, R. A. & Ahmed, R. CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection. J. Virol 70, 8375-8381 (1996).
29. Xu, J. et al Mice deficient for the D40 ligand. Immunity 1,423-431 (1994).
30. Kawabe, T. et al The immune responses in D40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity I, 167-178 (1994).